المؤلفون: Jarry U; Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Oncotrial, Rennes, France.; Biotrial Pharmacology, Unité de Pharmacologie Préclinique, Rennes, France., Bostoen M; Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Oncotrial, Rennes, France., Archambeau J; Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Oncotrial, Rennes, France.; Univ Rennes, INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Rennes, France., Pineau R; Univ Rennes, INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Rennes, France., Chaillot L; Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Oncotrial, Rennes, France.; Univ Rennes, INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Rennes, France., Jouan F; Univ Rennes, INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Rennes, France., Solhi H; Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Oncotrial, Rennes, France., Ferrari H; Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Oncotrial, Rennes, France., Le Guevel R; Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Oncotrial, Rennes, France., Mennessier V; Biotrial Pharmacology, Unité de Pharmacologie Préclinique, Rennes, France., Lena H; Univ Rennes, INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Rennes, France.; Centre Hospitalier Universitaire de Rennes, Univ Rennes, Rennes, France., Corre R; Univ Rennes, INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Rennes, France.; Centre Hospitalier Universitaire de Rennes, Univ Rennes, Rennes, France., Ricordel C; Univ Rennes, INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Rennes, France.; Centre Hospitalier Universitaire de Rennes, Univ Rennes, Rennes, France., Guillaudeux T; Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Oncotrial, Rennes, France.; Univ Rennes, INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Rennes, France., Pedeux R; Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Oncotrial, Rennes, France.; Univ Rennes, INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Rennes, France.

المصدر: PloS one [PLoS One] 2024 Jun 27; Vol. 19 (6), pp. e0304914. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Aniline Compounds*/pharmacology , Aniline Compounds*/therapeutic use , Acrylamides*/pharmacology , Afatinib*/pharmacology , Afatinib*/therapeutic use , Bevacizumab*/pharmacology , Bevacizumab*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/genetics, Animals ; Mice ; Humans ; Cell Line, Tumor ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Disease Models, Animal ; Xenograft Model Antitumor Assays ; ErbB Receptors/metabolism ; ErbB Receptors/genetics ; Quinazolines/pharmacology ; Quinazolines/therapeutic use ; Quinazolines/administration & dosage ; Piperazines/pharmacology ; Piperazines/therapeutic use ; Piperazines/administration & dosage ; Female ; Indoles ; Pyrimidines

المؤلفون: Jeon HL; School of Pharmacy and Institute of New Drug Development, Jeonbuk National University, Jeonju, Jeonbuk, Republic of Korea., Kwak M; School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon-si, Gyeonggi-do, Republic of Korea., Kim S; Yuhan Corporation, Seoul, Republic of Korea., Yu HY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea., Shin JY; School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon-si, Gyeonggi-do, Republic of Korea. shin.jy@skku.edu.; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Republic of Korea. shin.jy@skku.edu.; Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea. shin.jy@skku.edu., Jung HA; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea. hyunae.jung@samsung.com.

المصدر: Scientific reports [Sci Rep] 2024 Jun 25; Vol. 14 (1), pp. 14659. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/mortality , ErbB Receptors*/genetics , ErbB Receptors*/antagonists & inhibitors , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/mortality , Acrylamides*/therapeutic use , Aniline Compounds*/therapeutic use , Aniline Compounds*/pharmacology , Protein Kinase Inhibitors*/therapeutic use, Humans ; Male ; Female ; Aged ; Middle Aged ; Aged, 80 and over ; Treatment Outcome ; Progression-Free Survival ; Mutation ; Adult ; Pyrimidines/therapeutic use ; Indoles ; Morpholines ; Pyrazoles

المؤلفون: Horibe R; Department of Respiratory Medicine, NTT-East Corporation Sapporo Medical Center, Japan., Yokota M; Department of Respiratory Medicine, NTT-East Corporation Sapporo Medical Center, Japan., Uemura K; Department of Respiratory Medicine, NTT-East Corporation Sapporo Medical Center, Japan., Hashimoto M; Department of Respiratory Medicine, NTT-East Corporation Sapporo Medical Center, Japan., Kawagishi N; Department of Gastroenterology, NTT-East Corporation Sapporo Medical Center, Japan., Nishiyama K; Department of Respiratory Medicine, NTT-East Corporation Sapporo Medical Center, Japan.

المصدر: Internal medicine (Tokyo, Japan) [Intern Med] 2024 Jun 15; Vol. 63 (12), pp. 1797-1800. Date of Electronic Publication: 2023 Nov 06.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Hepatitis B virus*/genetics , Hepatitis B virus*/drug effects , Hepatitis B virus*/physiology , ErbB Receptors*/antagonists & inhibitors , Virus Activation*/drug effects , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/adverse effects , Aniline Compounds*/therapeutic use , Aniline Compounds*/adverse effects , Acrylamides*/therapeutic use , Acrylamides*/adverse effects , Hepatitis B*/drug therapy , Hepatitis B*/complications, Humans ; Female ; Aged ; Adenocarcinoma/drug therapy ; Adenocarcinoma/secondary ; Fatal Outcome ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/adverse effects ; Adenocarcinoma of Lung/drug therapy ; Tyrosine Kinase Inhibitors ; Indoles ; Pyrimidines

المؤلفون: Alagawani S; Department of Chemistry and Biotechnology, School of Science, Computing and Engineering Technologies, Swinburne University of Technology, Melbourne, VIC 3122, Australia., Vasilyev V; National Computational Infrastructure, Australian National University, Canberra, ACT 0200, Australia., Clayton AHA; Optical Sciences Centre, Department of Physics and Astronomy, School of Science, Computing and Engineering Technologies, Swinburne University of Technology, Melbourne, VIC 3122, Australia., Wang F; Department of Chemistry and Biotechnology, School of Science, Computing and Engineering Technologies, Swinburne University of Technology, Melbourne, VIC 3122, Australia.

المصدر: Molecules (Basel, Switzerland) [Molecules] 2024 Jun 12; Vol. 29 (12). Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE

مواضيع طبية MeSH: ErbB Receptors*/antagonists & inhibitors , ErbB Receptors*/chemistry , Quinazolines*/chemistry , Quinazolines*/pharmacology , Protein Kinase Inhibitors*/chemistry , Protein Kinase Inhibitors*/pharmacology , Halogens*/chemistry , Aniline Compounds*/chemistry , Aniline Compounds*/pharmacology, Humans ; Binding Sites ; Models, Molecular ; Structure-Activity Relationship

المؤلفون: Zhang N; Key Laboratory of Applied Surface and Colloid Chemistry of Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, P. R. China. liuth121@snnu.edu.cn., Chang H; Key Laboratory of Applied Surface and Colloid Chemistry of Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, P. R. China. liuth121@snnu.edu.cn., Miao R; Key Laboratory of Applied Surface and Colloid Chemistry of Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, P. R. China. liuth121@snnu.edu.cn., Liu T; Key Laboratory of Applied Surface and Colloid Chemistry of Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, P. R. China. liuth121@snnu.edu.cn., Ding L; Key Laboratory of Applied Surface and Colloid Chemistry of Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, P. R. China. liuth121@snnu.edu.cn., Fang Y; Key Laboratory of Applied Surface and Colloid Chemistry of Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, P. R. China. liuth121@snnu.edu.cn.

المصدر: Journal of materials chemistry. B [J Mater Chem B] 2024 Jun 05; Vol. 12 (22), pp. 5350-5359. Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101598493 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-7518 (Electronic) Linking ISSN: 2050750X NLM ISO Abbreviation: J Mater Chem B Subsets: MEDLINE

مواضيع طبية MeSH: Aniline Compounds*/chemistry , Aniline Compounds*/chemical synthesis , Fluorescent Dyes*/chemistry , Fluorescent Dyes*/chemical synthesis , Onions*/chemistry , Phenols*/chemistry , Phenols*/pharmacology , Cyclobutanes*/chemistry , Cyclobutanes*/chemical synthesis, Structure-Activity Relationship ; Photons ; Molecular Structure ; Optical Imaging ; Plant Cells

المؤلفون: Liang F; Bethune International Peace Hospital, Shijiazhuang, China., Zhang Y; Bethune International Peace Hospital, Shijiazhuang, China., Xue Q; Bethune International Peace Hospital, Shijiazhuang, China., Zhang X; Bethune International Peace Hospital, Shijiazhuang, China. zhangxiaoling201@163.com.

المصدر: Scientific reports [Sci Rep] 2024 Jun 03; Vol. 14 (1), pp. 12736. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Aniline Compounds*/pharmacokinetics , Aniline Compounds*/administration & dosage , Acrylamides*/pharmacokinetics , Acrylamides*/administration & dosage , ErbB Receptors*/genetics , ErbB Receptors*/metabolism , Brain Neoplasms*/secondary , Brain Neoplasms*/drug therapy, Humans ; Models, Biological ; Mutation ; Female ; Male ; Drug Interactions ; Protein Kinase Inhibitors/pharmacokinetics ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/blood ; Antineoplastic Agents/pharmacokinetics ; Antineoplastic Agents/blood ; Antineoplastic Agents/administration & dosage ; Middle Aged ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Indoles ; Pyrimidines

المؤلفون: Pizzutilo EG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy. Electronic address: elio.pizzutilo@unimi.it., Agostara AG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Oresti S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Signorelli D; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Stabile S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Lauricella C; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Motta V; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Amatu A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Ruggieri L; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Brambilla M; Dipartimento di Oncologia Medica, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan., Occhipinti M; Dipartimento di Oncologia Medica, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan; Department of Experimental Medicine, Sapienza University of Rome, Rome., Proto C; Dipartimento di Oncologia Medica, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan., Giusti R; Medical Oncology Unit, Sant'Andrea Hospital of Rome, Rome., Filetti M; Phase 1 Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome., Genova C; UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa; Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genoa., Barletta G; UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa., Gelsomino F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Bennati C; Ospedale S. Maria delle Croci, AUSL della Romagna, Ravenna., Siringo M; Medical Oncology Department, Umberto I - Policlinico di Roma, Rome., Di Fazio GR; Department of Medical Oncology Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome., Russano M; Department of Medical Oncology Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome., Montrone M; SSD Oncologia Medica per la Patologia Toracica, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari., Gariazzo E; Medical Oncology, Santa Maria Della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia., Roca E; Thoracic Oncology - Lung Unit, P. Pederzoli Hospital, Peschiera del Garda, Verona., Bordi P; Medical Oncology Unit, University Hospital of Parma, Parma., Delmonte A; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST), Meldola (FC)., Scimone A; Medical Oncology Department, Centro Oncologico Ospedale Papardo, Messina., Belluomini L; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona., Mazzoni F; Oncology department, Careggi University Hospital - Florence., Carta A; Ospedale Oncologico A. Businco, Cagliari., Pelizzari G; Dipartimento di Oncologia, Azienda Sanitaria Universitaria Friuli Centrale, Udine., Viscardi G; Oncologia Medica, Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Naples; Department of Pneumology and Oncology, AORN Ospedali dei Colli, Naples., Morgillo F; Oncologia Medica, Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Naples., Gelibter A; Medical Oncology Department, Umberto I - Policlinico di Roma, Rome., Gori S; Medical Oncology, IRCSS Sacro Cuore Don Calabria, Negrar di Valpolicella, Verona., Berardi R; Università Politecnica delle Marche - Azienda Ospedaliero Universitaria delle Marche, Ancona., Cortinovis D; SC Oncologia Medica Fondazione IRCCS San Gerardo dei Tintori, Monza., Ardizzoni A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Veronese SM; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Sartore-Bianchi A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy; Division of Clinical Research and Innovation, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Giannetta LG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Cerea G; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Siena S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.

المصدر: ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103592. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Acrylamides*/therapeutic use , Acrylamides*/pharmacology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , ErbB Receptors*/genetics , Aniline Compounds*/therapeutic use , Aniline Compounds*/pharmacology , Mutation*, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology ; Indoles ; Pyrimidines

المؤلفون: Lan J; College of Materials Engineering, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China., Xu L; College of Materials Engineering, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China., Wu Y; College of Materials Engineering, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China., Chen J; College of Materials Engineering, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China., Chen H; Fujian Fynex Textile Science and Technology Co. Ltd., Quanzhou, Fujian 362200, China., Huang J; Fujian Fynex Textile Science and Technology Co. Ltd., Quanzhou, Fujian 362200, China., Yong X; People's Hospital of Zhongning Country, Zhongwei, Ningxia 755100, China., Lu D; Key Lab for Sport Shoes Upper Materials, Fujian Huafeng New Material Co. Ltd., Putian 351164, China., Ma X; College of Materials Engineering, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China. Electronic address: 000Q151067@fafu.edu.cn., Cao S; College of Materials Engineering, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China. Electronic address: 000Q151052@fafu.edu.cn.

المصدر: International journal of biological macromolecules [Int J Biol Macromol] 2024 Jun; Vol. 272 (Pt 2), pp. 132772. Date of Electronic Publication: 2024 May 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0003 (Electronic) Linking ISSN: 01418130 NLM ISO Abbreviation: Int J Biol Macromol Subsets: MEDLINE

مواضيع طبية MeSH: Aniline Compounds*/chemistry , Aniline Compounds*/pharmacology , Cellulose*/chemistry , Cellulose*/pharmacology , Anti-Bacterial Agents*/pharmacology , Anti-Bacterial Agents*/chemistry, Electric Stimulation ; Sterilization/methods ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; Escherichia coli/drug effects ; Escherichia coli/growth & development ; Staphylococcus aureus/drug effects ; Levivirus/drug effects

المؤلفون: Tsukita Y; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan., Taguri M; Department of Health Data Science, Tokyo Medical University, Tokyo, Japan., Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Hosomi Y; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Mizutani T; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan., Watanabe K; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Yoh K; Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan., Takahashi S; Department of Thoracic Surgery, Tokyo Medical University, Tokyo, Japan., Kubota K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan., Kunitoh H; Department of Chemotherapy, Japan Red Cross Medical Center, Tokyo, Japan.

المصدر: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Jun 01; Vol. 54 (6), pp. 730-734.

نوع المنشور: Journal Article; Multicenter Study; Clinical Trial Protocol

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Aniline Compounds*/administration & dosage , Aniline Compounds*/therapeutic use , Acrylamides*/administration & dosage , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , ErbB Receptors*/genetics , Mutation*, Humans ; Aged ; Female ; Male ; Aged, 80 and over ; Dose-Response Relationship, Drug ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/therapeutic use ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Progression-Free Survival ; Indoles ; Pyrimidines

المؤلفون: Li Z; Department of Pharmacy, Dongguan Binhaiwan Center Hospital, Dongguan, China., Zou W; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Yuan J; Department of Pharmacy, Dongguan Binhaiwan Center Hospital, Dongguan, China., Zhong Y; Department of Pharmacy, Dongguan Binhaiwan Center Hospital, Dongguan, China., Fu Z; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

المصدر: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Jun; Vol. 23 (6), pp. 763-770. Date of Electronic Publication: 2023 Jul 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Acrylamides*/adverse effects , Acrylamides*/administration & dosage , Pharmacovigilance* , Aniline Compounds*/adverse effects , Aniline Compounds*/administration & dosage , Adverse Drug Reaction Reporting Systems*/statistics & numerical data , United States Food and Drug Administration*, Humans ; Male ; Female ; United States ; Sex Factors ; Middle Aged ; Aged ; Databases, Factual ; Adult ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/administration & dosage ; Aged, 80 and over ; Young Adult ; Indoles ; Pyrimidines